- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting the p53 Pathway for Therapy
Authors
Keywords
-
Journal
Cold Spring Harbor Perspectives in Medicine
Volume 7, Issue 3, Pages a026310
Publisher
Cold Spring Harbor Laboratory
Online
2017-02-14
DOI
10.1101/cshperspect.a026310
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges
- (2017) Shaomeng Wang et al. Cold Spring Harbor Perspectives in Medicine
- Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation
- (2016) Yoav Shetzer et al. Cold Spring Harbor Perspectives in Medicine
- Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End
- (2016) Amanda R. Wasylishen et al. Cold Spring Harbor Perspectives in Medicine
- Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
- (2015) Christopher J. Lord et al. Annual Review of Medicine
- Acute cytotoxicity of MIRA-1/NSC19630, a mutant p53-reactivating small molecule, against human normal and cancer cells via a caspase-9-dependent apoptosis
- (2015) Chantal Bou-Hanna et al. CANCER LETTERS
- Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
- (2015) Shengliang Zhang et al. CANCER RESEARCH
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
- (2015) Masatsugu Hiraki et al. CHEMISTRY & BIOLOGY
- Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
- (2015) Clare L. Scott et al. JOURNAL OF CLINICAL ONCOLOGY
- A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation
- (2015) Xishan Chen et al. JOURNAL OF CONTROLLED RELEASE
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- CRISPR-Cas9–based target validation for p53-reactivating model compounds
- (2015) Michael Wanzel et al. Nature Chemical Biology
- p53 in survival, death and metabolic health: a lifeguard with a licence to kill
- (2015) Flore Kruiswijk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish
- (2015) J S Chua et al. ONCOGENE
- Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice
- (2015) Amanda M. Goh et al. Oncotarget
- Analysis of p53 Transactivation Domain Mutants Reveals Acad11 as a Metabolic Target Important for p53 Pro-Survival Function
- (2015) Dadi Jiang et al. Cell Reports
- Microbial Regulation of p53 Tumor Suppressor
- (2015) Alexander I. Zaika et al. PLoS Pathogens
- Functional repair of p53 mutation in colorectal cancer cells using trans-splicing
- (2015) Xingxing He et al. Oncotarget
- Small molecule compounds targeting the p53 pathway: are we finally making progress?
- (2014) Xin Yu et al. APOPTOSIS
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
- (2014) Susann Weissmueller et al. CELL
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Mutant p53 reactivation by small molecules makes its way to the clinic
- (2014) Vladimir J.N. Bykov et al. FEBS LETTERS
- Wild type p53 reactivation: From lab bench to clinic
- (2014) Galina Selivanova FEBS LETTERS
- Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation
- (2014) Y. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38
- (2014) A Weilbacher et al. Cell Death & Disease
- Chlamydia infection depends on a functional MDM2-p53 axis
- (2014) Erik González et al. Nature Communications
- Tumor Suppressor p53 Alters Host Cell Metabolism to Limit Chlamydia trachomatis Infection
- (2014) Christine Siegl et al. Cell Reports
- Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
- (2014) Mary Ann Allen et al. eLife
- MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
- (2013) C. Tovar et al. CANCER RESEARCH
- A Potent Small-Molecule Inhibitor of the MDM2–p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
- (2013) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Phosphatase PP2A Links Glutamine to the Tumor Suppressor p53
- (2013) Dana Gwinn et al. MOLECULAR CELL
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression
- (2013) W Wang et al. Cell Death & Disease
- A Reversible Gene-Targeting Strategy Identifies Synthetic Lethal Interactions between MK2 and p53 in the DNA Damage Response In Vivo
- (2013) Sandra Morandell et al. Cell Reports
- Stapled Peptides with Improved Potency and Specificity That Activate p53
- (2012) Christopher J. Brown et al. ACS Chemical Biology
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
- (2012) P A J Muller et al. ONCOGENE
- Multiple Stress Signals Activate Mutant p53 In Vivo
- (2011) Y.-A. Suh et al. CANCER RESEARCH
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Validation of MdmX as a therapeutic target for reactivating p53 in tumors
- (2011) D. Garcia et al. GENES & DEVELOPMENT
- Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR
- (2011) David W. Schoppy et al. JOURNAL OF CLINICAL INVESTIGATION
- Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
- (2011) D. Li et al. MOLECULAR CANCER RESEARCH
- ROS-Mediated p53 Induction of Lpin1 Regulates Fatty Acid Oxidation in Response to Nutritional Stress
- (2011) Wissam Assaily et al. MOLECULAR CELL
- Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
- (2011) Philip M Reaper et al. Nature Chemical Biology
- Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
- (2011) Matilde Murga et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
- (2011) Luis I Toledo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Combining ATR Suppression with Oncogenic Ras Synergistically Increases Genomic Instability, Causing Synthetic Lethality or Tumorigenesis in a Dosage-Dependent Manner
- (2010) O. Gilad et al. CANCER RESEARCH
- Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53
- (2010) C F Cheok et al. CELL DEATH AND DIFFERENTIATION
- p53 activates the PANK1/ miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins
- (2010) Levin Böhlig et al. NUCLEIC ACIDS RESEARCH
- Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells
- (2010) L Sauer et al. ONCOGENE
- Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species
- (2010) S. Suzuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
- (2009) A Oden-Gangloff et al. BRITISH JOURNAL OF CANCER
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
- (2009) F. M. Speetjens et al. CLINICAL CANCER RESEARCH
- The combined status of ATM and p53 link tumor development with therapeutic response
- (2009) H. Jiang et al. GENES & DEVELOPMENT
- RETRACTED: GAMT, a p53-Inducible Modulator of Apoptosis, Is Critical for the Adaptive Response to Nutrient Stress
- (2009) Takao Ide et al. MOLECULAR CELL
- Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53
- (2009) Yaroslava Ruzankina et al. NATURE GENETICS
- Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
- (2009) J. P. Morton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Origins and Evolution of the p53 Family of Genes
- (2009) V. A. Belyi et al. Cold Spring Harbor Perspectives in Biology
- Posttranslational Modification of p53: Cooperative Integrators of Function
- (2009) D. W. Meek et al. Cold Spring Harbor Perspectives in Biology
- Clinical Outcomes and Correlates of TP53 Mutations and Cancer
- (2009) A. I. Robles et al. Cold Spring Harbor Perspectives in Biology
- Targeting activity of a TCR/IL-2 fusion protein against established tumors
- (2008) Jinghai Wen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now